Fosamprenavir: all 27 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Oral Fosamprenavir for GERDNot yet recruitingNCT06704100Phase 2
- Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme ReductionRecruitingNCT04383262Phase 2
- An Interaction Study to Assess Drug Levels in Fasting Healthy Adult SubjectsCompletedNCT00802074Not applicableResults posted
- An Interaction Study to Assess Drug Levels in Healthy Adult SubjectsCompletedNCT00764465Phase 2Results posted
- An Interaction Study to Assess Drug Levels in Healthy Adult SubjectsCompletedNCT00614991Not applicableResults posted
- HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive AdultsCompletedNCT00450580Phase 3Results posted
- A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected SubjectsCompletedNCT00296504Phase 3Results posted
- Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy SubjectsCompletedNCT01290211Phase 1
- HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With FosamprenavirCompletedNCT01222611Phase 4
- GSK1349572 Drug Interaction Study With Fosamprenavir/RitonavirCompletedNCT01209065Phase 1
- Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy SubjectsTerminatedNCT01140412Phase 1
- Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)CompletedNCT00977301Phase 1
- Interaction of Buprenorphine With HIV Medications and Tuberculosis MedicationsCompletedNCT00877591Phase 1
- Pharmacokinetic Study of Posaconazole Boosted FosamprenavirCompletedNCT00817765Phase 1
- VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.CompletedNCT00775125Phase 1
- Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.CompletedNCT00481182Phase 1
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedNCT00307502Phase 1
- Fosamprenavir Expanded AccessCompletedNCT00240552Phase 4
- A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and AmprenavirCompletedNCT00148785Phase 4
- Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV SubjectsTerminatedNCT00144833Phase 3
- Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)CompletedNCT00122603Phase 2
- Fosamprenavir Versus Other Protease InhibitorsCompletedNCT00094523Phase 3
- KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedNCT00085943Phase 3
- Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIRCompletedNCT00043888Phase 3
- Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological FailureStatus unknownNCT00025727Phase 3
- Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral DrugsStatus unknownNCT00009061Phase 3
- Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral TherapyStatus unknownNCT00008554Phase 3